N‐terminal pro‐B‐type natriuretic peptide improves the predictive value of CHA(2)DS(2)‐VASc risk score for long‐term cardiovascular events in acute coronary syndrome patients with atrial fibrillation

BACKGROUND: It is important to identify patients with co‐morbid acute coronary syndrome (ACS) and atrial fibrillation (AF) at high risk and adopt proper management strategies to improve their prognosis. HYPOTHESIS: The addition of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) could improve p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Xuefei, Qiu, Miaohan, Li, Yi, Li, Ziqi, Qi, Bin, Jing, Zilan, Jing, Quanmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Clinical Trial Result
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352965/
https://www.ncbi.nlm.nih.gov/pubmed/37218400
http://dx.doi.org/10.1002/clc.24037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352965/
https://www.ncbi.nlm.nih.gov/pubmed/37218400
http://dx.doi.org/10.1002/clc.24037

Ejemplares similares